GENNEX
Gennex Laboratories financials
- Market cap
- ₹231 Cr
Quarterly results
Q1 FY27: revenue up 16.6%, net profit down 6.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33 | 40 | 40 | 34 | 39 +18% | 43 +7% | 61 +51% | 40 +17% |
| EBITDA | 7 | 7 | 2 | 5 | 8 +1% | 9 +20% | 6 +192% | 4 −14% |
| Net profit | 5 | 5 | 3 | 5 | 6 +2% | 6 +19% | 4 +45% | 5 −7% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −3.1% 1Y
1Y: ₹11.45 on 10 Sept 2025 → ₹11.1. High ₹17.02 (28 Oct 2025), low ₹7.13 (30 Mar 2026).
Financials, as filed
Revenue grew 39.2% a year over 2 years, FY24 to FY26. Operating margin narrowed to 15.3%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹92 Cr | ₹142 Cr | ₹177 Cr |
| Operating profit | ₹22 Cr | ₹21 Cr | ₹27 Cr |
| Operating margin | 23.9% | 14.7% | 15.3% |
| Interest | ₹3 Cr | ₹3 Cr | ₹4 Cr |
| Depreciation | ₹2 Cr | ₹3 Cr | ₹3 Cr |
| Net profit | ₹13 Cr | ₹18 Cr | ₹21 Cr |
| Net margin | 14.4% | 12.8% | 11.8% |
| Cash from operations | ₹-47 Cr | ₹-11 Cr | ₹-64 Cr |
| Free cash flow | ₹-31 Cr | ₹-20 Cr | ₹-76 Cr |
| ROCE | 14.0% | 13.0% | 11.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹13 Cr | ₹13 Cr | ₹18 Cr | ₹23 Cr | ₹24 Cr | ₹24 Cr |
| Reserves | ₹27 Cr | ₹31 Cr | ₹62 Cr | ₹148 Cr | ₹189 Cr | ₹198 Cr |
| Borrowings | ₹7 Cr | ₹10 Cr | ₹1 Cr | ₹6 Cr | ₹88 Cr | ₹79 Cr |
| Other liabilities | ₹12 Cr | ₹14 Cr | ₹51 Cr | ₹54 Cr | ₹55 Cr | ₹47 Cr |
| Total liabilities | ₹59 Cr | ₹68 Cr | ₹132 Cr | ₹230 Cr | ₹357 Cr | ₹349 Cr |
| Fixed assets | ₹14 Cr | ₹14 Cr | ₹74 Cr | ₹56 Cr | ₹76 Cr | ₹61 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹0 Cr | ₹13 Cr |
| Investments | ₹7 Cr | ₹7 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹38 Cr | ₹48 Cr | ₹59 Cr | ₹172 Cr | ₹281 Cr | ₹275 Cr |
| Total assets | ₹59 Cr | ₹68 Cr | ₹132 Cr | ₹230 Cr | ₹357 Cr | ₹349 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters added +3.81 pp while the public trimmed −3.79 pp. The shareholder count shrank 9% to 82,886.
- Promoters
- 23.6%
- Public
- 76.4%
Since Jun 2025
- Promoters +3.81 pp
- Public −3.79 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 23.6%, Public 76.4%.Dec '23: Promoters 23.6%, Public 76.4%.Mar '24: Promoters 18.4%, Public 81.6%.Jun '24: Promoters 18.4%, Public 81.6%.Sep '24: Promoters 18.4%, Public 81.6%.Dec '24: Promoters 18.4%, Public 81.6%.Mar '25: Promoters 18.4%, Public 81.6%.Jun '25: Promoters 19.8%, Public 80.2%.Sep '25: Promoters 23.6%, Public 76.4%.Dec '25: Promoters 23.6%, Public 76.4%.Mar '26: Promoters 23.6%, Public 76.4%.Jun '26: Promoters 23.6%, Public 76.4%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Anupriya Consultants Pvt Ltd newly disclosed 1.84% held
The same filing shows 1 holder trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of Gennex Laboratories Ltd above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Premier Fiscal Services Private Limited | 21.83% | unchanged |
| Jms Mines & Minerals Private Limited | 3.25% | unchanged |
| Anupriya Consultants Pvt Ltd | 1.84% | newly disclosed |
| Dorite Tracon Private Limited | 1.56% | −0.33 pp |
| Sanjay Kumar | 1.53% | unchanged |
| Vab Ventures Limited | 1.42% | unchanged |
| Rajababu Sampatrao Bandela | 1.41% | unchanged |
| Subhash Chand Bhura Trusteeof Anuj Bhura Welfare Trust | 0.32% | unchanged |
| Prudential Investment Limited | 0.02% | unchanged |
| Vinod Baid | 0.02% | unchanged |
| India Securities Brooking Private Limited | 0.02% | unchanged |
| Gopalakrishnan Muralidharan Tiruvarur | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse Gennex Laboratories Ltd
Guides on how to read this kind of business and the numbers that matter.